Sinovac Biotech Ltd. Receives Vaccine Order for China Earthquake Victims

May 28, 2008 -- Sinovac Biotech Ltd. (AMEX: SVA) said China’s Ministry of Health placed a 20 million RMB ($2.9 million) order for Healive®, the company’s inactivated hepatitis A vaccine, which will be administered to people living in the earthquake-affected provinces of Sichuan, Shanxi and Gansu. More details...

Back to news